Retour aux projets

26118.2 PFLS-LS

A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies

Résumé

A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies

Textes supplémentaires

Abstract

Capitalizing on programmable cell fate regulation, we present a high-content screening platform measuring the differentiation capacity of pluripotent stem cells in a rapid, non-disruptive and inexpensive manner, enabling identification of high-quality stem cells for commercial applications.

Participants

Martin Fussenegger

Kontaktperson

fussenegger@bsse.ethz.ch

ETH Zürich department of biosystems science an D-BSSE Martin Fussenegger Mattenstrasse 26 4058 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2018-02-28
Date de fin
2019-08-31
Coûts totaux approuvés
CHF 336936.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%